Stock screenerAll disclosures →
EDGAR →
KYMR
Conviction 100HealthcareScan · Thu, Jun 25, 2026KYMR$116.34+16.49%
ResistanceSupportVol 14Insider sell48
4
Vol MA14 1.19M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price116.34
Change+16.49%
Gap+7.45%
Rel volume4.60×
Avg volume1.02M
Avg $ vol94.56M
SMA 2085.01
SMA 5084.33
SMA 20074.76
Price vs 50+37.97%
Price vs 200+55.63%
MA stackbullish
50/200 cross—
Supertrendup · 96.41
RSI (14)84
MACD hist3.44
MACD crossbull · 9d
Stoch %K / %D76 / 80
ADX (14)32
+DI / −DI58 / 6
RSI divergence—
MACD divergence—
ATR %+5.51%
ADR %6.02%
52w high116.34
52w low37.68
From 52w high+0.00%
Above 52w low+208.76%
New 52w highYes
SqueezeOff
Bollinger width52.69%
%B1.20
Donchian pos77.44%
Donchian high129.99
Donchian low69.48
AVWAP (52w high)117.88
vs AVWAP high-1.31%
AVWAP (52w low)74.02
vs AVWAP low+57.18%
OBV trendUp
Chaikin MF (20)0.06
Today vs 20d4.60×
Avg vol (14d)1.19M
Avg vol (20d)1.02M
Avg $ vol (20d)94.56M
Market cap9.57B
RS 3m (vs SPY)+21.94%
RS 6m (vs SPY)+11.17%
RS line new highYes
Trend template8/8
Technical rank94.0
1 week+29.41%
1 month+44.04%
3 months+47.40%
6 months+37.93%
1 year+146.80%
YTD+59.90%
P/E-30.74
P/B6.22
P/S244.06
P/FCF-40.84
EPS-3.69
Div yield—
ROE-20.22%
ROA-18.65%
Debt/Eq—
Current10.81
EV/EBITDA-27.63
Gross margin—
Net margin-794.04%
Rev growth-16.70%
EPS growth-39.08%
Price target119.13
Target upside2.40%
Analyst ratingBuy
Institutional125.37%
Ent. value9.43B
Revenue34.37M
Net income-69.23M
Gross profit—
Free cash flow-234.34M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out82.26M
Employees253
ListedFri, Aug 21, 2020
Free float24.21M
Float %77.2%
Short interest10.1M
Days to cover20.6d
Short volume68.0%
Squeeze score99 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.71 vs −$0.89
Last surprise+20.2% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank94.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance97.23
Support73.18
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KYMR
No recent disclosed trades by Congress in KYMR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KYMR · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 1.52K | $188K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 337 | $44K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 5.14K | $616K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 15.66K | $1.9M | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 698 | $86K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 1.64K | $204K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 522 | $66K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 223 | $28K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 3.51K | $447K | 2026-06-25 | 2026-06-25 |
Booth Bruce Director · Common Stock · 2026-06-25 | Sell | 305 | $39K | 2026-06-25 | 2026-06-25 |
SEC filings
EDGAR filings in KYMR · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.